Know Cancer

or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Oklahoma City

    Trial Locations
    Veterans Affairs Medical Center - Oklahoma City
    University of Oklahoma Health Sciences Center
    Lymphoma
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    Oklahoma University Medical Center
    Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Head and Neck Cancer
    Surgery in Treating Patients With Prostate Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Sarcoma
    S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
    University of Oklahoma
    Oklahoma City, Oklahoma 73190
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    Children's Hospital of Oklahoma
    Oklahoma City, Oklahoma 73104
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73126
    Melanoma (Skin), Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Leukemia
    Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Myelodysplastic Syndromes, Sarcoma
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    Oklahoma Memorial Hospital
    Oklahoma City, Oklahoma 73126-0307
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Bladder Cancer
    Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Leukemia
    Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    STI571 in Treating Patients With Recurrent Leukemia
    Children's Hospital of Oklahoma
    Oklahoma City, Oklahoma 73104
    Leukemia
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center

    Trial Locations
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Frank C. Love Cancer Institute at St. Anthony Hospital
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    St. Anthony Hospital
    Oklahoma City, Oklahoma 73101
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Head and Neck Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73126
    Breast Cancer
    Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73126
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Breast Cancer
    Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Childhood Embryonal Tumor, Childhood Extracranial Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Ovarian Embryonal Carcinoma, Ovarian Yolk Sac Tumor, Stage II Malignant Testicular Germ Cell Tumor, Stage IIA Ovarian Germ Cell Tumor, Stage IIB Ovarian Germ Cell Tumor, Stage IIC Ovarian Germ Cell Tumor, Stage III Malignant Testicular Germ Cell Tumor, Stage IIIA Ovarian Germ Cell Tumor, Stage IIIB Ovarian Germ Cell Tumor, Stage IIIC Ovarian Germ Cell Tumor, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Mercy Health Center

    Trial Locations
    Mercy Health Center
    Integris Oncology Services
    Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Cancer Care Associates - Mercy Campus

    Trial Locations
    Cancer Care Associates - Mercy Campus
    Cancer Care Associates at Troy and Dollie Smith Cancer Center
    Breast Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Mercy Campus
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Stem Cell Transplantation in Individuals With Multiple Myeloma
    University of Oklahoma Medical Center
    Oklahoma City, Oklahoma 73104
    Multiple Myeloma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adenocarcinoma of the Colon, Stage III Colon Cancer